The impact of left atrial mechanics on adverse events and clinical outcome after cardiac surgery.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
04 10 2022
Historique:
received: 23 12 2021
revised: 12 04 2022
accepted: 06 05 2022
pubmed: 11 5 2022
medline: 2 11 2022
entrez: 10 5 2022
Statut: ppublish

Résumé

Postoperative atrial fibrillation (POAF) represents a common complication after cardiac surgery that is associated with unfavourable clinical outcome. Identifying patients at risk for POAF is crucial but challenging. This study aimed to investigate the prognostic potential of speckle-tracking echocardiography on POAF and fatal adverse events from a long-term perspective. A total of 124 patients undergoing elective cardiac surgery were prospectively enrolled and underwent preoperative speckle-tracking echocardiography. Patients were followed prospectively for the occurrence of POAF within the entire hospitalization and reaching the secondary end points cardiovascular and all-cause mortality. Within the study population 43.5% (n = 53) of enrolled individuals developed POAF. After a median follow-up of 3.9 years, 25 (20.2%) patients died. We observed that patients presenting with POAF had lower global peak atrial longitudinal strain (PALS) values compared to the non-POAF arm {POAF: 14.8% [95% confidence interval (CI): 10.9-17.8] vs non-POAF: 19.4% [95% CI: 14.8-23.5], P < 0.001}. Moreover, global PALS was a strong and independent predictor for POAF [adjusted odds ratio per 1 standard deviation: 0.37 (95% CI: 0.22-0.65), P < 0.001] and independently associated with mortality [adjusted hazard ratio per 1 standard deviation: 0.63 (95% CI: 0.40-0.99), P = 0.048]. Classification and Regression Tree analysis revealed a cut-off value of <17% global PALS as high risk for both POAF and mortality. Global PALS is associated with the development of POAF following surgery in an unselected patient population undergoing CABG and/or valve surgery. Since patients with global PALS <17% face a poor long-term prognosis, routine assessment of global PALS needs to be considered in terms of proper secondary prevention in the era of personalized medicine.

Identifiants

pubmed: 35536199
pii: 6583179
doi: 10.1093/ejcts/ezac275
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Daniel Dalos (D)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Sophie Selina Haaser (SS)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Felix Hofer (F)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Niema Kazem (N)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Lorenz Koller (L)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Andreas Hammer (A)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Barbara Steinlechner (B)

Department of Anesthesiology, Medical University of Vienna, Vienna, Austria.

Günther Laufer (G)

Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.

Christian Hengstenberg (C)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Alexander Niessner (A)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Patrick Sulzgruber (P)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH